본문 바로가기
KERD
논문KCI 등재

유방암종에서 p27kip1 단백의 세포 내 발현 위치와 예후와의 관련성

Subcellular Localization of p27kip1 in Breast Cancer and Its Prognostic Significance

홍영습|김대철|조세헌|홍숙희
대한병리학회|2006.06|Journal of Pathology and Translational Medicine|제40권 제3호|pp. 185-192

2

조회

0

다운로드

0

인용

0

참고문헌

주제분류병리학

초록

Abstract

Background : p27 is a member of the cyclin-dependent kinase (CDK)inhibitors that arrest the progression of the cell cycle; thus, it acts as a tumor suppressor gene. The loss or decrease of p27 protein is frequently seen and this has an independent prognostic potential for many human cancers. p27 is functionally inactivated through accelerated proteolysis and cytoplasmic sequestration. Cytoplasmic mislocalization of p27 by abnormal phosphorylation in the tumor cells doesn’t allow it to bind and inhibit nuclear cyclin/CDK targets. Methods : We examined the p27 protein expression in 86 cases of invasive ductal carcinoma of the breast via immunohistochemical staining to evaluate the subcellular localization of p27 and its relationship with the clinicopathologic features and the prognostic factors. Results : The nuclear expression of p27 was noted in 48.9% of the tumors, a combined nuclear and cytoplasmic expression was noted in 20.9%, a cytoplasmic expression was noted in 12.8%, and a negative expression was noted in 17.4%. The decreased nuclear expression and/or cytoplasmic mislocalization of p27 were statistically correlated with the nuclear grade (p=0.001), histologic grade (p=0.036), tumor size (p=0.033), lymph node metastasis (p=0.043), ER (p=0.001), and PR (p=0.001) status, while they were not correlated with patient age, stage, HER2, p53, and Ki67. Conclusions : The breast tumors showing both decreased nuclear expression and cytoplasmic mislocalization of p27 are associated with a deranged cell cycle via functional inactivation and also with poor prognostic factors. It is expected that p27 can be a promising anticancer target molecule for the treatment of breast cancer.

참고문헌 (28)

  1. "Multiple functions of p27Kip1 and its alterations in tumor cells:a review", 183, pp.18~27 (2000)
  2. "Localization and expression of p27Kip1 in multistage colorectal carcinogenesis", 58, pp.114~122 (1998)
  3. "Mice lacking p27 (Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors", 85, pp.707~720 (1996)
  4. "The cell cycle inhibitor p27 is an independent prognostic marker in small (T1a,b) invasive breast carcinomas", 57, pp.1259~1263 (1997)
  5. "Prognostic role of p27Kip1 and apoptosis in human breast cancer", 79, pp.1572~1578 (1999)
  6. "Low expression of p27Kip1 is associated with tumor size and poor prognosis in patients with renal cell carcinoma", 94, pp.973~979 (2002)
  7. "Overexpressed cyclin D3 contributes to retaining the growth inhibitor p27 in the cytoplasm of thyroid tumor cells", 104, pp.865~874 (1999)
  8. "Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27Kip1 by PKB", Akt-mediated phosphorylation in breast cancer, 2002, pp.8, 1136~1144
  9. "Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin during G1 and prevents nuclear re-entry", 280, pp.6055~6063 (2005)
  10. "PKB", Akt phosphorylates p27,impairs nuclear import of p27 and apposes p27-mediated G1 arrest, 2002, pp.8, 1153~1160
  11. "The role of cyclin-dependent kinase inhibitor p27Kip1 in anti-HER2 antibody-induced G1 cell cycle arrest and tumor growth inhibition", 278, pp.23441~23450 (2003)
  12. "Inducible expression of a degradation-resistant form of p27Kip1 causes growth arrest and apoptosis in breast cancer cells", 579, pp.3932~3940 (2005)
  13. "Frequent loss of expression of the cyclin-dependent kinase inhibitor p27 in epithelial ovarian cancer", 59, pp.3790~2794 (1999)
  14. "The prognostic significance of p27 and cyclin E in human breast cancer", 1, pp.241~250 (1998)
  15. "Significance of the expression of p27Kip1 protein in human breast cancer", 5, pp.291~297 (2002)
  16. "Cyclin E,p27 and mutant p53 donot predict the prognosis in AJCC stage II colorectal carcinomas", 44, pp.314~20 (2004)
  17. "Expression of p34cdc2,p27Kip1,p21WAR1", Cip1 and p53 in human breast cancers, 2005, pp.39, 391~400
  18. "Immunohistochemical study of p27Kip1 expression ingastric adenomas and early gastric carcinoma -analysis of 65 cases-", 37, pp.325~332 (2003)
  19. "High p27Kip1 expression predicts superior relapse-free and overall survival for premenopausal women with early-stage breast cancer receiving adjuvant treatment with tamoxifen plus goserelin", 21, pp.3594~3600 (2003)
  20. "P27kip1 downregulation is associated with trastuzumab resistance in breast cancer cells", 64, pp.3981~3986 (2004)
  21. "Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2", neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status:results from international breast cancer study group trial V, 2003, pp.97, 1591~1600
  22. "High level expression of p27kip1 and cyclin D1 in some human breast cancer cells:inverse correlation between the expression of p27kip1 and degree of malignancy in human breast and colorectal cancers", 94, pp.6380~6385 (1997)
  23. "Expression of p27kip1 in breast cancer and its prognostic significance", 201, pp.451~459 (2003)
  24. "P27kip1 expression in breast carcinomas:an immunohistochemical study on 512 patients with long-term follow-up", 89, pp.236~241 (2000)
  25. "High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas:relation to E-cadherin alterations,proliferative activity,and ploidy of the tumors", 94, pp.2454~2465 (2002)
  26. "Akt-dependent T198 phosphorylation of cyclin-dependent kinase inhibitor p27kip1 in breast cancer", 3, pp.1074~1080 (2004)
  27. "Novel p27kip1 C-terminal scatter domain mediates Rac-dependent cell migration independent of cell cycle arrest functions", 23, pp.216~228 (2003)
  28. "Oncogenic signals of HER-2", neu in regulating the stability of the cyclin-dependent kinase inhibitor p27, 2000, pp.275, 24735~24739

관련 논문AI추천

인체 유방암종에서 p34cdc2, p27Kip1, p21WAF1/Cip1 및 p53의 발현김동훈, 김은경, 박찬금, 이원미, 이호정, 주종은대한병리학회 · Journal of Pathology and Translational Medicine2005 · 제39권 제6호유방의 침윤성 관암종에서 p21, p53 및 bcl-2 단백의 발현문형배, 윤기중, 조향정대한병리학회 · Journal of Pathology and Translational Medicine2003 · 제37권 제6호유방의 침윤성 관암종에서 Anaphase-promoting Complex의 발현과 예후 인자와의 관계강엽, 박광화, 엄민섭, 이광길, 이상엽, 정순희대한병리학회 · Journal of Pathology and Translational Medicine2003 · 제37권 제1호위샘종과 조기 위암에서 p27Kip1 단백 발현에 관한 면역조직화학적 연구 - 65증례의 분석 -명나혜대한병리학회 · Journal of Pathology and Translational Medicine2003 · 제37권 제5호유방 병변의 악성 진행에 따른 Survivin 단백 발현강석진, 강창석, 유진영, 이교영, 이은정, 정지한, 정찬권, 최현주대한병리학회 · Journal of Pathology and Translational Medicine2007 · 제41권 제4호유방암종에서 p130Cas 및 FHIT의 발현과 예후인자와의 상관성 연구강석진, 강창석, 유진영, 정지한, 최현주대한병리학회 · Journal of Pathology and Translational Medicine2005 · 제39권 제1호

이 간행물의 다른 논문 (11건)

EBV Encoded RNA 양성 위암에서 EBV Latent Membrane Protein 1 유전자 변화와 TGF-β1, TGF-βRII, p21,p16, E2F1, Thymidylate Synthase 및 NF-κB 단백 발현에대한 면역조직화학적 연구김명수, 최선주, 엄민섭, 성승훈, 김미동, 조미연, 박광화, 김대성pp. 176-184대장암 병리보고서 기재사항 표준화채양석, 김윤화, 김호근, 김영배, 송규상, 배한익, 장희진, 장희경, 장미수, 박철근, 김우호pp. 193-203한국인 전립선 선암종의 병리학적 분석: 83예의 지도화 분석이유정, 이강현, 홍은경, 김동일, 이희은, 이건국, 박원서, 원재경pp. 204-209난소암에서 c-Abl, c-Kit, Platelet-derived Growth FactorReceptor (PDGFR)-α, PDGFR-β 의 발현과 예후의 관계이희정, 이교영, 강창석, 이근호pp. 210-216곧창자 샘암종에서 세포주기 조절 단백 발현:수술 전 방사선화학 치료 반응 및 예후에 미치는 영향이교영, 최현주, 유진영, 정지한, 강석진, 신정하, 강창석pp. 217-224
원문 보기